Pharmacotherapeutic efficacy of the use of pelargonium sidovid root extract in the prevention and treatment of respiratory diseases

Relevance in research infectious and inflammatory diseases of the upper respiratory tract caused by high prevalence, variability clinical manifestations severity disease with risk developing complications. Respiratory are a cause functional morphological disorders mucosa which is protective barrier against various damaging agents. It necessary to use complex drugs that preserve restore physiological activity mucous membrane as much possible. In this regard, there great interest plant medical product (extract roots pelargonium sidovid chief active ingredient) causes stimulation nonspecific mechanisms, beating frequency cilia ciliated epithelium, NK cells, phagocytes, modulation synthesis interferon proinflammatory cytokines, expression adhesive molecules, chemotaxis. We can notice moderate direct antibacterial antiviral properties extract. The pharmacotherapeutic efficacy containing an extract was analysed our treatment diseases. There literature review about safety preparations liquid roots. effectiveness confirmed results investigation: children adults digest drug, greatly facilitates course diseases, prevents development complications, reduces duration acute infections. Extract easy dosage. All these make it possible include therapy tract.